#MedCase - A rare clinical scenario involving ankylosing spondylitis diagnosed in a woman with a history of successfully treated osteoarticular brucellosis.
Is it a causal association or separate pathology?

#MedCase - A rare clinical scenario involving ankylosing spondylitis diagnosed in a woman with a history of successfully treated osteoarticular brucellosis.
Is it a causal association or separate pathology?
NEW RESEARCH—Efficacy and safety of rozanolixizumab in severe fibromyalgia: a phase 2A randomised, double-blind, placebo-controlled, multicentre trial www.thelancet.com/journals/lan... #MedSky #RheumSky
The relationship between rheumatoid arthritis and reproductive health is multifaceted.
Familiarize yourself with the current evidence on fertility, birth outcomes, and other sexual and reproductive health topics as they relate to the condition.
NEW COMMENT—Beyond vasomotor symptoms: reframing musculoskeletal health in the Women's Health Strategy www.thelancet.com/journals/lan...
#MedSky #RheumSky #WomensHealthSky
Goal-directed #osteoporosis treatment: are bone mineral density targets valid? www.thelancet.com/journals/lan...
#BMD
#OpenAccess
Despite the availability of safe and effective therapies for #osteoporosis, these therapies are underused in individuals at high risk for #fracture, calling for better case-finding and fracture risk assessment strategies www.thelancet.com/journals/lan...
#AI #ML
Although #fracture risk is often lower in #osteopenic women than in those with #osteoporosis, their greater number means that most fractures occur in osteopenic individuals www.thelancet.com/journals/lan...
#osteopenia
#Fractures affect a substantial proportion of people with #obesity and result from reduced #bone strength relative to increased mechanical loading, together with an increased risk of #falls www.thelancet.com/journals/lan...
#osteoporosis
NEW PERSONAL VIEW—Prehabilitation in rheumatology: a missing link in psoriatic disease management www.thelancet.com/journals/lan...
#MedSky #RheumSky @stefansiebert.bsky.social
🆕 Visual Abstract with Healio 🎨
#Deucravacitinib in Psoriatic Arthritis: POETYK PsA-2
🎲 Phase 3 RCT of Deucravacitinib vs PBO
💊 Deucravacitinib = oral, selective TYK2 inhibitor
🥇 1st FDA-approved TYK2i for PsA
Healio Article 🔗: vist.ly/5hps8
Setback - Novartis and BMS pause their CD19 CAR-T research program (automimmune, not cancer)
www.reuters.com/business/hea...
3 deaths from IEC-HPS
❗️LAST CHANCE TO REGISTER❗️
Join our expert-led webinar to learn how to best approach difficult-to-treat rheumatoid arthritis.
Register for free here 👉️ buff.ly/wO7Khfr